in this issue
World News and Views :: Top of the News
Johnson & Johnson to Buy Remaining Stake in Crucell for €1.75 Billion (update)
4:19 AM MDT | September 21, 2010 | Deepti Ramesh
Biopharmaceutical company Crucell (Leiden, Netherlands) says that it is in advanced negotiations with Johnson & Johnson (J&J; New Brunswick, NJ), for a potential public offer by J&J for all outstanding ordinary shares of Crucell that it does not already own. In September 2009, J&J has purchased about 18% of Crucell’s ordinary shares for a total purchase price of €302 million ($396 million). J&J or an affiliate will acquire all outstanding equity of Crucell that it does not already own for about €1.75 billion, which represents a...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee